- AU$177.57m
- AU$160.67m
- $70.05m
- 17
- 40
- 85
- 48
R2019 December 31st | R2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 60.2 | 90.1 | 112 | 116 | 70 |
Cost of Revenue | |||||
Gross Profit | 9.72 | 27.6 | 23.1 | 26.9 | 19.1 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 92.6 | 88.9 | 115 | 124 | 77.9 |
Operating Profit | -32.4 | 1.2 | -2.96 | -8.06 | -7.86 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -29.4 | -6.69 | -11 | -15.3 | -16.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -31.3 | -5.93 | -11.2 | -15.3 | -15.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -31.4 | -17 | -14.7 | -16.2 | -16 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -31.4 | -17 | -14.7 | -16.2 | -16 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.044 | -0.004 | -0.014 | -0.018 | -0.02 |